Here's the hot new trend in Wall Street research note titles: emoticons.
From Piper Jaffray on Thursday:
And we're having some fun with the title, but it's actually really apt!
In results reported Wednesday after the close, Vanda's treatment for pruritis — VLY-686 — improved symptoms in some patients, but so did placebo. Oh well.
Piper added that there still remains potential for VLY-686 to move forward with successful development.
In morning trade on Thursday, Vanda shares were down about 3%.
NOW WATCH: Nationwide's Super Bowl commercial about dead children is about corporate profits ... in a way that we can all appreciate
See Also:A grocery chain no one talks about is becoming Whole Foods' biggest threatJohn McCain's explanation for why he doesn't use email is absolute gold Why this tech bubble is worse than the tech bubble of 2000